Germany: Third party interventions to ex parte proceedings

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Germany: Third party interventions to ex parte proceedings

In a decision (BGH X ZB 4/14, "Verdickerpolymer II"), the German Federal Court of Justice (BGH) has resolved the question of third party interventions to ex parte proceedings. The BGH found that there is no legal basis for third party interventions to ex parte proceedings of the patent proprietor requesting reinstatement even when the third party is sued for infringement of the patent in suit.

The German part of European patent EP 682 094, maintained in amended form after opposition proceedings, lapsed in Germany because the proprietor failed to pay the publication fee and provide a German translation of the amended patent within the legal deadlines. The patent proprietor requested reinstatement and a third party being sued for infringement of the patent in suit requested intervention to the reinstatement proceedings.

Section 59(2) PatG provides a legal basis for third party interventions to inter-partes opposition proceedings in the case of pending infringement or declaratory proceedings. Section 44(2) PatG explicitly excludes third party interventions to ex-parte grant proceedings.

The BGH found that the lack of a provision concerning a third party intervention to ex-parte proceedings if the third party is sued for infringement of the patent in suit is not considered as an unplanned legal loophole. The restrictive character of the provisions for third party interventions indicates a conclusive nature that cannot be generalised. It is emphasised that reinstatement proceedings are ancillary proceedings conducted in the course of main proceedings and if third party interventions to main proceedings are only allowed under exceptional circumstances similar hurdles must apply for associated ancillary proceedings.

With respect to decision BGH X ZB 26/70 "Hopfenextrakt", wherein an opponent was allowed to participate in reinstatement proceedings, it is emphasised that this decision has been issued under the previous law and is based on the prerequisite that opposition proceedings are conducted as part of grant proceedings. The decision is not considered applicable when opposition proceedings and grant proceedings are independent from each other.

It has been clarified that a third party intervention to ancillary proceedings is only allowable if the third party is involved in the corresponding main proceedings. Furthermore, the existing provisions on third party interventions are considered conclusive.

Tim Pust


Maiwald Patentanwalts GmbHElisenhof, Elisenstr 3D-80335, Munich, GermanyTel: +49 89 74 72 660 Fax: +49 89 77 64 24info@maiwald.euwww.maiwald.eu

more from across site and SHARED ros bottom lb

More from across our site

Selina Hinchliffe, head of commercial services at Shakespeare Martineau, reflects on rejecting Cambridge, leading through empathy, and why authenticity matters more than fitting in
US corporates are using the UPC, but much of that work still flows to European boutiques. Last week’s merger, as well as others, could alter that dynamic
Publicly listed Australian group IPH delivered on its promise to profoundly shake up the Canadian market. Four years on, rivals have had time to adapt
IP practitioners debate whether new guidelines will make it more difficult to challenge a patent
Varuni Paranavitane says she is excited to bring ‘rounded expertise’ to the firm, which will have a solicitor in its ranks for the first time
Lawyers adapting to AI-driven recommendations are being pushed to demonstrate expertise publicly rather than simply relying on a polished website
Mid-market businesses looking to establish an online presence need ‘holistic’ brand protection services at an accessible cost, according to partners
Our latest update also includes the latest case filing statistics, and an update on how a transatlantic merger could be a UPC opportunity for the US half of the partnership
New partners, from biotech company Leyden Labs and Novartis, take the total number of partner hires to 12 since the firm took on external investment in late 2024
Labelled the ‘largest law firm merger in history’, the new outfit could also spell an opportunity for US clients to capitalise on Hogan Lovells' UPC expertise
Gift this article